Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
risdiplam
US tariffs, IP issues threaten patient access
The judgements on the Roche Natco case for SMA medicine risdiplam could impact petitions from patients suffering from other rare…
Roche gets US FDA approval for Evrysdi to treat spinal muscular atrophy
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of…
Roche’s SMA drug trial win bolsters $2 billion sales prospects
US regulators are due to decide by May 24